178 related articles for article (PubMed ID: 22742453)
21. A putative gene cluster for aminoarabinose biosynthesis is essential for Burkholderia cenocepacia viability.
Ortega XP; Cardona ST; Brown AR; Loutet SA; Flannagan RS; Campopiano DJ; Govan JR; Valvano MA
J Bacteriol; 2007 May; 189(9):3639-44. PubMed ID: 17337576
[TBL] [Abstract][Full Text] [Related]
22. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides.
McCoy AJ; Liu H; Falla TJ; Gunn JS
Antimicrob Agents Chemother; 2001 Jul; 45(7):2030-7. PubMed ID: 11408219
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of the Burkholderia cenocepacia K56-2 essential genome reveals cell envelope functions that are uniquely required for survival in species of the genus Burkholderia.
Gislason AS; Turner K; Domaratzki M; Cardona ST
Microb Genom; 2017 Nov; 3(11):. PubMed ID: 29208119
[TBL] [Abstract][Full Text] [Related]
24. An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli.
Yan A; Guan Z; Raetz CR
J Biol Chem; 2007 Dec; 282(49):36077-89. PubMed ID: 17928292
[TBL] [Abstract][Full Text] [Related]
25. Lipopolysaccharides in bacterial membranes act like cholesterol in eukaryotic plasma membranes in providing protection against melittin-induced bilayer lysis.
Allende D; McIntosh TJ
Biochemistry; 2003 Feb; 42(4):1101-8. PubMed ID: 12549932
[TBL] [Abstract][Full Text] [Related]
26. Chemical synthesis of Burkholderia Lipid A modified with glycosyl phosphodiester-linked 4-amino-4-deoxy-β-L-arabinose and its immunomodulatory potential.
Hollaus R; Ittig S; Hofinger A; Haegman M; Beyaert R; Kosma P; Zamyatina A
Chemistry; 2015 Mar; 21(10):4102-14. PubMed ID: 25630448
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of the arn operon and loss of aminoarabinose on lipopolysaccharide as the cause of susceptibility to colistin in an atypical clinical isolate of proteus vulgaris.
Baron S; Leulmi Z; Villard C; Olaitan AO; Telke AA; Rolain JM
Int J Antimicrob Agents; 2018 Mar; 51(3):450-457. PubMed ID: 29203405
[TBL] [Abstract][Full Text] [Related]
28. Characterization of liposomes formed by lipopolysaccharides from Burkholderia cenocepacia, Burkholderia multivorans and Agrobacterium tumefaciens: from the molecular structure to the aggregate architecture.
D'Errico G; Silipo A; Mangiapia G; Vitiello G; Radulescu A; Molinaro A; Lanzetta R; Paduano L
Phys Chem Chem Phys; 2010 Nov; 12(41):13574-85. PubMed ID: 20852798
[TBL] [Abstract][Full Text] [Related]
29. PmrD is required for modifications to escherichia coli endotoxin that promote antimicrobial resistance.
Rubin EJ; Herrera CM; Crofts AA; Trent MS
Antimicrob Agents Chemother; 2015 Apr; 59(4):2051-61. PubMed ID: 25605366
[TBL] [Abstract][Full Text] [Related]
30. The complete structure and pro-inflammatory activity of the lipooligosaccharide of the highly epidemic and virulent gram-negative bacterium Burkholderia cenocepacia ET-12 (strain J2315).
Silipo A; Molinaro A; Ieranò T; De Soyza A; Sturiale L; Garozzo D; Aldridge C; Corris PA; Khan CM; Lanzetta R; Parrilli M
Chemistry; 2007; 13(12):3501-11. PubMed ID: 17219455
[TBL] [Abstract][Full Text] [Related]
31. Targeting the Nonmevalonate Pathway in Burkholderia cenocepacia Increases Susceptibility to Certain β-Lactam Antibiotics.
Sass A; Everaert A; Van Acker H; Van den Driessche F; Coenye T
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439968
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia.
Scoffone VC; Spadaro F; Udine C; Makarov V; Fondi M; Fani R; De Rossi E; Riccardi G; Buroni S
Antimicrob Agents Chemother; 2014; 58(4):2415-7. PubMed ID: 24395233
[TBL] [Abstract][Full Text] [Related]
33. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
Drevinek P; Mahenthiralingam E
Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
[TBL] [Abstract][Full Text] [Related]
34. Burkholderia cenocepacia Lipopolysaccharide Modification and Flagellin Glycosylation Affect Virulence but Not Innate Immune Recognition in Plants.
Khodai-Kalaki M; Andrade A; Fathy Mohamed Y; Valvano MA
mBio; 2015 Jun; 6(3):e00679. PubMed ID: 26045541
[TBL] [Abstract][Full Text] [Related]
35. Thermodynamic analysis of the lipopolysaccharide-dependent resistance of gram-negative bacteria against polymyxin B.
Howe J; Andrä J; Conde R; Iriarte M; Garidel P; Koch MH; Gutsmann T; Moriyón I; Brandenburg K
Biophys J; 2007 Apr; 92(8):2796-805. PubMed ID: 17237210
[TBL] [Abstract][Full Text] [Related]
36. The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia.
Mil-Homens D; Bernardes N; Fialho AM
FEMS Microbiol Lett; 2012 Mar; 328(1):61-9. PubMed ID: 22150831
[TBL] [Abstract][Full Text] [Related]
37. Vitamin E Increases Antimicrobial Sensitivity by Inhibiting Bacterial Lipocalin Antibiotic Binding.
Naguib MM; Valvano MA
mSphere; 2018 Dec; 3(6):. PubMed ID: 30541778
[No Abstract] [Full Text] [Related]
38. Glycosyltransferases involved in the biosynthesis of the inner core region of different lipopolysaccharides.
Gronow S; Xia G; Brade H
Eur J Cell Biol; 2010 Jan; 89(1):3-10. PubMed ID: 19900730
[TBL] [Abstract][Full Text] [Related]
39. Polymyxin Binding to the Bacterial Outer Membrane Reveals Cation Displacement and Increasing Membrane Curvature in Susceptible but Not in Resistant Lipopolysaccharide Chemotypes.
Santos DES; Pol-Fachin L; Lins RD; Soares TA
J Chem Inf Model; 2017 Sep; 57(9):2181-2193. PubMed ID: 28805387
[TBL] [Abstract][Full Text] [Related]
40. Unusual interaction of a lipopolysaccharide isolated from Burkholderia cepacia with polymyxin B.
Shimomura H; Matsuura M; Saito S; Hirai Y; Isshiki Y; Kawahara K
Infect Immun; 2003 Sep; 71(9):5225-30. PubMed ID: 12933868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
